Kejako

About:

Kejako develops a non-invasive solution for interested presbyopic patients seeking to keep their quality of life.

Top Investors: MassChallenge, FONGIT, Business Angels Switzerland (BAS)

Description:

Kejako develops a non-invasive solution for interested presbyopic patients seeking to keep their quality of life through the compensation of visual accommodation decay. Addressing presbyopia in the field of ophthalmology, with an anti-aging mindset in order to treat the gradual loss of visual accommodation. Kejako SA is a privately held company founded in March 2015 and based in Geneva, Switzerland. The company address presbyopia in the field of ophthalmology with a breakthrough approach combining simulation and minimally invasive treatment: all-in-one solution.

Total Funding Amount:

1.45M CHF

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Geneve, Geneve, Switzerland

Founded Date:

2015-01-01

Founders:

David Enfrun, Gilles Bos

Number of Employees:

1-10

Last Funding Date:

2022-08-01

IPO Status:

Private

Industries: